Peptazol medicine for the treatment of duodenal ulcers, which are ulcers that form at the beginning of the small intestine, and simple gastric ulcers, which are non-cancerous ulcers that form in the stomach as a result of increased secretion of stomach acid, and
Peptazol for the treatment of ulcers resulting from non-steroidal anti-inflammatory drugs, which are ulcers that form in the intestines as a result of excessive use of non-steroidal anti-inflammatory drugs and analgesics, and the treatment of esophageal reflux, also known as heartburn, acid esophagitis, and pathological hypersecretion conditions, which are problems in the digestive tract that lead to increased acid secretion.